Giavarina Davide, Lippi Giuseppe
Clinical Laboratory, St. Bortolo Hospital, Vicenza, Italy.
Section of Clinical Biochemistry, University of Verona, Verona, Italy.
Clin Biochem. 2017 Jul;50(10-11):568-573. doi: 10.1016/j.clinbiochem.2017.02.021. Epub 2017 Feb 27.
The extra-analytical phases of the total testing process have substantial impact on managed care, as well as an inherent high risk of vulnerability to errors which is often greater than that of the analytical phase. The collection of biological samples is a crucial preanalytical activity. Problems or errors occurring shortly before, or soon after, this preanalytical step may impair sample quality and characteristics, or else modify the final results of testing. The standardization of fasting requirements, rest, patient position and psychological state of the patient are therefore crucial for mitigating the impact of preanalytical variability. Moreover, the quality of materials used for collecting specimens, along with their compatibility, can guarantee sample quality and persistence of chemical and physical characteristics of the analytes over time, so safeguarding the reliability of testing. Appropriate techniques and sampling procedures are effective to prevent problems such as hemolysis, undue clotting in the blood tube, draw of insufficient sample volume and modification of analyte concentration. An accurate identification of both patient and blood samples is a key priority as for other healthcare activities. Good laboratory practice and appropriate training of operators, by specifically targeting collection of biological samples, blood in particular, may greatly improve this issue, thus lowering the risk of errors and their adverse clinical consequences. The implementation of a simple and rapid check-list, including verification of blood collection devices, patient preparation and sampling techniques, was found to be effective for enhancing sample quality and reducing some preanalytical errors associated with these procedures. The use of this tool, along with implementation of objective and standardized systems for detecting non-conformities related to unsuitable samples, can be helpful for standardizing preanalytical activities and improving the quality of laboratory diagnostics, ultimately helping to reaffirm a "preanalytical" culture founded on knowledge and real risk perception.
整个检测过程的分析前阶段对管理式医疗有着重大影响,并且存在固有的高错误风险,这种风险通常大于分析阶段。生物样本的采集是一项关键的分析前活动。在这个分析前步骤之前不久或之后不久出现的问题或错误可能会损害样本质量和特性,或者改变检测的最终结果。因此,禁食要求、休息、患者体位和患者心理状态的标准化对于减轻分析前变异性的影响至关重要。此外,用于采集标本的材料质量及其兼容性能够保证样本质量以及分析物的化学和物理特性随时间的持续性,从而保障检测的可靠性。适当的技术和采样程序可有效防止诸如溶血、血样在采血管中过度凝血、采集样本量不足以及分析物浓度改变等问题。如同其他医疗活动一样,准确识别患者和血样是关键优先事项。良好的实验室规范以及对操作人员进行专门针对生物样本采集(尤其是血液采集)的适当培训,可能会极大地改善这个问题,从而降低错误风险及其不良临床后果。实施一个简单快速的检查表,包括对采血设备、患者准备和采样技术的核查,被发现对于提高样本质量以及减少与这些程序相关的一些分析前错误是有效的。使用这个工具,以及实施用于检测与不合适样本相关的不符合项的客观标准化系统,有助于规范分析前活动并提高实验室诊断质量,最终有助于重申基于知识和实际风险认知的“分析前”文化。